Becton, Dickinson and Company

BDX ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $1.10B $976.0M $695.0M $1.19B $1.29B $1.17B $1.27B $1.32B
Depreciation & Amortization $1.09B $1.11B $891.0M $562.0M $546.0M $511.0M $494.0M $491.4M
Depreciation $406.0M $452.0M $417.0M $369.0M $338.0M $321.0M $340.0M $338.2M
Amortization $553.0M $552.0M $346.0M $84.0M $83.0M $71.0M $54.0M $47.0M
Stock-Based Compensation $174.0M $196.0M $166.0M $113.0M $100.0M $89.0M $73.0M $79.4M
Net Cash from Operating Activities $2.55B $2.56B $1.73B $1.75B $1.72B $1.69B $1.64B $1.59B
Investing Activities
Capital Expenditures $727.0M $693.0M $596.0M $592.0M $522.0M $487.0M $509.0M $531.0M
Business Acquisitions $174.0M $0 $8.41B $40.0M $136.0M $103.0M $492.0M $281.4M
Net Cash from Investing Activities $-883.0M $-669.0M $-8.32B $-948.0M — — — —
Financing Activities
Dividends Paid $677.0M $562.0M $485.0M $421.0M $386.0M $368.0M $361.0M $345.7M
Stock Repurchases $220.0M $0 $0 $400.0M $450.0M $1.50B $1.50B $750.0M
Net Cash from Financing Activities $10.98B $-1.76B $6.19B $-807.0M — — — —
Net Change in Cash $12.64B $117.0M $-436.0M $-29.0M $219.0M $496.0M $-41.0M $-178.3M
Free Cash Flow $1.82B $1.87B $1.13B $1.15B $1.20B $1.21B $1.13B $1.06B
← Newer Page 2 of 3 Older →